NOS3 and hereditary angioedema: eNOS is known to increase in patients with HAE both in the attack and in the remission phase and there are reports of significant differences in levels of other vasoactive mediators-vascular endothelial growth factors (VEGFs), angiopoietins (ANGPTs) and phospholipase A2 enzymes (PLA2) [29,39].